Artificial Intelligence for Drug Discovery: An Update and Future Prospects

Seminars in Nuclear Medicine, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

---

Translating the multifaceted use of liquid biopsy to management of early disease in pancreatic adenocarcinoma

Frontiers in Oncology, Journal Year: 2025, Volume and Issue: 15

Published: March 13, 2025

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related mortality, primarily due to late stage at diagnosis. This review examines the multifaceted applications liquid biopsy and circulating tumor DNA (ctDNA) analysis in diagnosis management PDAC. We current literature on technological advancements such as next generation sequencing (NGS) digital droplet PCR (ddPCR) well multi-omics technologies, highlighting their potential for accurate molecular subtyping through ctDNA analysis. highlights significant role assessment behavior, disease subtyping, prediction monitoring treatment response, evaluation minimal residual disease. discuss implications integrating techniques into clinical practice its challenges limitations. By drawing insights from recent studies, this aims provide comprehensive overview how can enhance early strategies underscore need additional prospective studies trials validate feasibility accuracy order establish utility, with ultimate goal routine incorporation improve patient outcomes transform landscape

Language: Английский

---

Liquid Biopsy and Imaging Are Complementary for Assessing Tumor Burden

Radiology, Journal Year: 2024, Volume and Issue: 313(2)

Published: Nov. 1, 2024

Language: Английский

---